COMMUNIQUÉS West-GlobeNewswire

Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)
13/06/2019
Provides funding for additional preclinical experiments and for the MYODA preparations for the clinical study in Duchenne muscular dystrophy (DMD) PARIS and CAMBRIDGE, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Biophytis [...]
Organovo to Present at Raymond James Life Sciences and MedTech Conference
13/06/2019
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Immutep Completes Recruitment of Initial Cohort in 1st Line NSCLC Patients for TACTI-002 Trial
13/06/2019
Recruitment for 2 nd line (PD-1 refractory) NSCLC and 2 nd line HNSCC cohorts of the TACTI-002 trial, conducted in collaboration with MSD, are ongoing Initial data from the TACTI-002 study expected mid-2019 SYDNEY, [...]
Bellerophon to Present at the JMP Securities Life Sciences Conference
13/06/2019
WARREN, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief [...]
Executive Women In Bio Celebrates the 30th Board Appointment for Boardroom Ready Program Alumnae
13/06/2019
Sharon Ayd, Ph.D., appointed as independent director at Reglagene NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Executive Women In Bio (EWIB), a group of senior leaders committed to promoting, empowering and elevating [...]
IBEX Reports Results For The Third Quarter And The Nine Months Ended April 30, 2019
13/06/2019
MONTRÉAL, Québec, June 13, 2019 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the nine months ended April 30, 2019. “As predicted, the [...]
Spero Announces $10 Million Registered Direct Offering of Common Stock
13/06/2019
Novo Holdings A/S through its Novo REPAIR Impact Fund to Invest Up to $10 million Net Proceeds to Advance Spero’s SPR720 CAMBRIDGE, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a [...]
Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Update on Etigilimab (TIGIT) Partnership
13/06/2019
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN LONDON and [...]
Houston Methodist Selects Tabula Rasa HealthCare’s DoseMe For System-wide Precision Dosing Technology
13/06/2019
MOORESTOWN, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc.’s (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a multi-year [...]
Entasis Therapeutics Announces Initial ETX0282 Phase 1 Results
13/06/2019
WALTHAM, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious drug-resistant infections [...]
iCAD Introduces ProFound AI™ for 2D Mammography in Europe
13/06/2019
Company to showcase its newest artificial intelligence software solution, ProFound AI for 2D Mammography, in addition to ProFound AI for Digital Breast Tomosynthesis at the SIFEM Medical Conference in France NASHUA, N.H [...]
Telix Pharmaceuticals and Eczacıbaşı-Monrol Sign Manufacturing and Distribution Agreement
13/06/2019
MELBOURNE, Australia and ISTANBUL, Turkey, June 13, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Novo Nordisk A/S - Share repurchase programme
13/06/2019
Bagsværd, Denmark, 13 June 2019 - On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants
13/06/2019
Identification of pathogenic structural variants with SMRT Sequencing improves solve rate for rare and Mendelian diseases MENLO PARK, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- While DNA sequencing tools have been useful [...]
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection
13/06/2019
Findings from major health centers to be presented at ASM Microbe 2019 GAITHERSBURG, Md., June 13, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today that data from its Acuitas ® AMR Gene Panel and [...]
Amicus Therapeutics Adds Key Executives in Gene Therapy Science and Global Commercial Leadership
13/06/2019
Jill Weimer, PhD named Senior Vice President of Discovery Research and Gene Therapy Science Simon Jordan named Senior Vice President of International CRANBURY, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics [...]
Stemline Therapeutics Announces Three ELZONRIS (tagraxofusp) Clinical Presentations at EHA Congress June 13-15
13/06/2019
NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
G1 Therapeutics Announces Updates to Board of Directors
13/06/2019
- Garry Nicholson to serve as new board chair - - Sir Andrew Witty, Fredric Eshelman, Pharm.D. and prior chair Seth Rudnick, M.D. re-elected - RESEARCH TRIANGLE PARK, N.C., June 13, 2019 (GLOBE NEWSWIRE) -- G1 [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2019
WATERTOWN, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

Pages